Show items per page
Elements: 3
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study Van Cutsem, E; Dirix, L; Van Laethem, J-L; Van Belle, S; ... Bleiberg, H 2005
add to browser selection
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial Roth, Arnaud; Maibach, R; Fazio, N; Sessa, C; ... de Braud, F 2004
add to browser selection
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO) Roth, Arnaud; Maibach, R; Martinelli, G; Fazio, N; ... Goldhirsch, A 2000